VLS-01

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameVLS-01
Drug Alias NameN N-dimethyltryptamineN,N-二甲基色胺N-N-dimethyltryptamineN,N-DimethyltryptamineBuccal Film DMT +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor partial agonistsSerotonin 2a (5-HT2a) receptor partial agonistsSerotonin 2c (5-HT2c) receptor partial agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorDepressive Disorder +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlgernon Pharmaceuticals IncBiomind Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlgernon Pharmaceuticals IncAtai Therapeutics IncUniversidade Federal Do Rio Grande Do Norte +[6] 
Inactive CompaniesPharmaTher Inc
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorDepressive Disorder +[6] 
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG